Category: News

Australian health and wellness brands company Wellnex Life will bring registered medicinal cannabis and hemp-based products to domestic and international markets, via a newly formed joint venture with OneLife Botanicals.

The US Food and Drug Administration has granted ‘orphan drug designation’ to PTX-100 for the treatment of peripheral T-cell lymphomas, paving the way for Prescient Therapeutics to lock in years of market exclusivity.

Australian share markets lost $74 billion in February when Russia invaded Ukraine, leaving many strong companies lost or forgotten in the flurry of the sell-off.

Australia’s labour shortage is becoming a real crisis. Businesses are struggling to fill 300,000 jobs, says the National Skills Commission, while the ABS puts combined private and public sector vacancies at 480,000 – 111% higher than in February 2020, prior to the pandemic.

No fewer than 374 ‘cash burners’ and 180 ‘zombies’ can be found lurking on the ASX, a former Thorney Investment Group fund manager has revealed – representing a significant opportunity for investors.

It’s the ATM coin trick that an increasing number of young Australians are using to create profits out of thin air – but not everyone is caught up in the magic of the new ‘coin noodling’ craze.

A nationwide scheme created to help small businesses recover from the impacts of the coronavirus crisis has come to an end at a rather inopportune time – just days before a fresh surge in COVID cases around the country.

A key US patent for Prescient Therapeutics’ OmniCAR platform has been granted, the Australian biotech company has announced, ensuring protection in the American healthcare market until at least 2039.

Far East Gold has received more positive news out of Indonesia, with the government giving its formal approval on air emissions and the company yielding promising results from epithermal sample metallurgical test work at its Wonogiri Project site.

Roughly 125,000 Americans die every year after prematurely stopping treatment with prescription medications – a problem MedAdvisor hopes to end.

More than eight million Australians are living with at least one long-term health condition, the Australian Bureau of Statistics reported yesterday.

Tomorrow marks the end of the financial year and what a rollercoaster of highs and lows it has been for investors in 2022 so far.